NO144071C - Analogifremgangsmaate ved fremstilling av antihypertensivt aktive thienyl- og thietyl-ureaer - Google Patents

Analogifremgangsmaate ved fremstilling av antihypertensivt aktive thienyl- og thietyl-ureaer

Info

Publication number
NO144071C
NO144071C NO751351A NO751351A NO144071C NO 144071 C NO144071 C NO 144071C NO 751351 A NO751351 A NO 751351A NO 751351 A NO751351 A NO 751351A NO 144071 C NO144071 C NO 144071C
Authority
NO
Norway
Prior art keywords
thietyl
urea
preparation
analogy procedure
antihypertensive active
Prior art date
Application number
NO751351A
Other languages
English (en)
Norwegian (no)
Other versions
NO751351L (cs
NO144071B (no
Inventor
Paul Edward Aldrich
Gilbert Harvey Berezin
Bruce Ivor Dittmar
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of NO751351L publication Critical patent/NO751351L/no
Publication of NO144071B publication Critical patent/NO144071B/no
Publication of NO144071C publication Critical patent/NO144071C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO751351A 1974-04-17 1975-04-16 Analogifremgangsmaate ved fremstilling av antihypertensivt aktive thienyl- og thietyl-ureaer NO144071C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (3)

Publication Number Publication Date
NO751351L NO751351L (cs) 1975-10-20
NO144071B NO144071B (no) 1981-03-09
NO144071C true NO144071C (no) 1981-06-17

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
NO751351A NO144071C (no) 1974-04-17 1975-04-16 Analogifremgangsmaate ved fremstilling av antihypertensivt aktive thienyl- og thietyl-ureaer

Country Status (21)

Country Link
US (1) US4009847A (cs)
JP (1) JPS50148349A (cs)
AR (1) AR208545A1 (cs)
CA (1) CA1047042A (cs)
CH (1) CH611292A5 (cs)
DD (1) DD117223A5 (cs)
DE (1) DE2516554A1 (cs)
DK (1) DK164175A (cs)
ES (1) ES436648A1 (cs)
FI (1) FI751128A7 (cs)
FR (1) FR2267773B1 (cs)
GB (1) GB1461209A (cs)
HU (1) HU173052B (cs)
IE (1) IE41143B1 (cs)
IL (1) IL47095A (cs)
LU (1) LU72306A1 (cs)
NL (1) NL7504570A (cs)
NO (1) NO144071C (cs)
PH (1) PH11722A (cs)
SE (1) SE417965B (cs)
YU (1) YU96075A (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6344476B1 (en) * 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
HK1042251B (en) * 1999-01-13 2012-07-20 Bayer Healthcare Llc Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
RU2319693C9 (ru) * 1999-01-13 2008-08-20 Байер Копэрейшн Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
RU2316326C2 (ru) * 2001-12-03 2008-02-10 Байер Фамэсьютиклс Копэрейшн Способ и композиция для лечения ракового заболевания, тозилат и фармацевтически приемлемые соли n-(4-хлор-3-(трифторметил)фенил)-n'-(4-(2-(n-метилкарбамоил)-4-пиридилокси)фенил)мочевины
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
EP2324825A1 (en) 2002-02-11 2011-05-25 Bayer Healthcare LLC Aryl ureas with angiogenesis inhibiting activity
AU2003209119A1 (en) 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
ES2378670T3 (es) 2002-02-11 2012-04-16 Bayer Healthcare, Llc Aril ureas como inhibidores de cinasas
AU2003210969A1 (en) * 2002-02-11 2003-09-04 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
JP4860474B2 (ja) * 2003-05-20 2012-01-25 バイエル、ファーマシューテイカルズ、コーポレイション Ｐｄｇｆｒによって仲介される病気のためのジアリール尿素
AU2004259760B9 (en) * 2003-07-23 2011-02-03 Bayer Healthcare Llc Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
EP2295427A1 (en) * 2004-04-30 2011-03-16 Bayer HealthCare, LLC Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
NO751351L (cs) 1975-10-20
DK164175A (da) 1975-10-18
AR208545A1 (es) 1977-02-15
LU72306A1 (cs) 1976-03-17
NO144071B (no) 1981-03-09
FI751128A7 (cs) 1975-10-18
HU173052B (hu) 1979-02-28
SE417965B (sv) 1981-04-27
DD117223A5 (cs) 1976-01-05
IL47095A0 (en) 1975-06-25
US4009847A (en) 1977-03-01
FR2267773A1 (cs) 1975-11-14
AU8013575A (en) 1976-10-21
JPS50148349A (cs) 1975-11-27
CH611292A5 (cs) 1979-05-31
FR2267773B1 (cs) 1978-08-18
YU96075A (en) 1983-04-27
NL7504570A (nl) 1975-10-21
CA1047042A (en) 1979-01-23
PH11722A (en) 1978-05-30
IE41143L (en) 1975-10-17
DE2516554A1 (de) 1975-10-30
IE41143B1 (en) 1979-10-24
ES436648A1 (es) 1977-08-01
SE7503523L (sv) 1975-10-20
IL47095A (en) 1978-03-10
GB1461209A (en) 1977-01-13

Similar Documents

Publication Publication Date Title
NO144071C (no) Analogifremgangsmaate ved fremstilling av antihypertensivt aktive thienyl- og thietyl-ureaer
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO142402C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzimidazoler
NO143576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO143942C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive heterocyklisk substituerte guanidiner
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
SE420727B (sv) Analogiforfarande for framstellning av bispidin- och bispidonderivat
NO147109C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive diazepin-derivater
NO146774C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperazin- og piperidinderivater
NO143315C (no) Analogifremgangsmaate ved fremstilling av farmakologisk aktive bis-imidazol-derivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO141207C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenylalkylaminer
SE423996B (sv) Forfarande for framstellning av daunomycin- och adriamycin-derivat
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO146096C (no) Analogifremgangsmaate ved fremstilling av thienothiazinderivater
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO143381C (no) Analogifremgangsmaate ved fremstilling av farmakologisk aktive guanidin- og isotioureaderivater
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
NO144457C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner